SCHEMBL7929314

SCHEMBL7929314

COc1ccc(NC(=O)CCCCCC(=O)O)c(OC)n1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HDAC3 O15379 4/20 0.52
HDAC1 Q13547 4/20 0.52
MAPT P10636 1/20 0.48
MAPK1 P28482 1/20 0.48
HDAC4 P56524 3/20 0.46
HDAC2 Q92769 3/20 0.46
HDAC8 Q9BY41 3/20 0.46
HDAC6 Q9UBN7 3/20 0.46
HDAC9 Q9UKV0 3/20 0.46
HDAC7 Q8WUI4 2/20 0.46
HDAC10 Q969S8 2/20 0.46
HDAC11 Q96DB2 2/20 0.46
HDAC5 Q9UQL6 2/20 0.46
TDP1 Q9NUW8 4/20 0.46
POLB P06746 1/20 0.46
GAA P10253 3/20 0.44
KMT2A Q03164 1/20 0.44
HTT P42858 1/20 0.42
L3MBTL1 Q9Y468 2/20 0.41
KDM4E B2RXH2 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3235360 0.84 HDAC3 (0.72) HDAC3HDAC1HDAC4HDAC2HDAC8
SCHEMBL7933392 0.79 MAPT (0.53) HDAC3HDAC1MAPTMAPK1TDP1
SCHEMBL6561044 0.78 MAPT (0.58) HDAC3HDAC1MAPTMAPK1TDP1
SCHEMBL7929328 0.77 KCNQ4 (0.43) HDAC3HDAC1MAPTMAPK1HDAC2
SCHEMBL13298958 0.76 GAA (0.56) HDAC3HDAC1MAPTHDAC4HDAC2
SCHEMBL8152611 0.75 PTGS2 (0.42) HDAC3HDAC1MAPK1HDAC4HDAC2
SCHEMBL7932753 0.75 HDAC3 (0.47) HDAC3HDAC1MAPTMAPK1HDAC4
SCHEMBL1061122 0.72 HDAC3 (0.82) HDAC3HDAC1MAPTHDAC4HDAC2
SCHEMBL27909121 0.71 HDAC3 (0.79) HDAC3HDAC1MAPTHDAC4HDAC2
SCHEMBL8161847 0.69 GAA (0.61) HDAC3HDAC1MAPTHDAC4HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010028193-A1 COMPOUNDS INCLUDING PIMELIC ACID DERIVATIVES AS HDAC INHIBITORS REPLIGEN CORPORATION (US) 2010-03-11 WO disclosed